Skip to main content
NCBI home page
The British Journal of Ophthalmology logoLink to The British Journal of Ophthalmology
. 1990 Oct;74(10):615–619. doi: 10.1136/bjo.74.10.615

Therapeutic outcome of patients suffering from malignant melanomas of the conjunctiva.

P K Lommatzsch 1, R E Lommatzsch 1, I Kirsch 1, P Fuhrmann 1
PMCID: PMC1042232  PMID: 2285686

Abstract

Eighty-one cases of conjunctival melanoma treated between 1960 and 1988 were studied to determine factors that might affect outcome in patients with such lesions. The therapeutic procedures performed were local excision (16), local excision followed by brachytherapy with Sr-90/Y-90 (32), local excision followed by cryotherapy with liquid nitrogen (16), brachytherapy with Sr-90/Y-90 (12), local excision followed by external beam irradiation (3), and local excision followed by brachytherapy and cryotherapy (2). The median follow-up period was 5.5 years (longest 26, shortest 1 year). Sixty two patients (76.5%) showed a complete regression of the melanoma, 19 (23.5%) developed recurrences, and 15 (18.5%) died from metastases. The melanomas had developed with almost equal frequency from a pre-existing naevus (25.9%), from primary acquired melanosis (25.9%), and 'de novo' (30.9%). Small tumours had a higher chance of regressing (80.6%) than larger ones (68.6%). The cumulative survival rate was 76% after five years and 60% after 10 years from any causes of death and 87.6% after five years and 76.3% after 10 years from deaths caused by metastases. Most deaths from metastases occurred within 5 years. At 88.5%, the cumulative survival rate of patients with small tumours (less than one quadrant of the bulbar conjunctiva and less than 2 mm thickness) was significantly higher than that of patients with larger tumours (more than one quadrant of the bulbar conjunctiva and/or more than 2 mm thickness) with 65% after eight years. Local excision followed by beta ray irradiation (Sr-90/Y-90) or cryotherapy can be recommended as the treatment of choice. Nevertheless the behaviour of conjunctival melanomas remains unpredictable in individual cases.

Full text

PDF
615

Images in this article

618Image
on p.618
618Image
on p.618
619Image
on p.619
619Image
on p.619
619Image
on p.619

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Folberg R., McLean I. W., Zimmerman L. E. Malignant melanoma of the conjunctiva. Hum Pathol. 1985 Feb;16(2):136–143. doi: 10.1016/s0046-8177(85)80062-9. [DOI] [PubMed] [Google Scholar]
  2. Fuchs U., Kivelä T., Liesto K., Tarkkanen A. Prognosis of conjunctival melanomas in relation to histopathological features. Br J Cancer. 1989 Feb;59(2):261–267. doi: 10.1038/bjc.1989.55. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Jakobiec F. A., Brownstein S., Wilkinson R. D., Katzin H. M. Adjuvant cryotherapy for focal nodular melanoma of the conjunctiva. Arch Ophthalmol. 1982 Jan;100(1):115–118. doi: 10.1001/archopht.1982.01030030117013. [DOI] [PubMed] [Google Scholar]
  4. Jakobiec F. A. Conjunctival melanoma. Arch Ophthalmol. 1980 Aug;98(8):1378–1384. doi: 10.1001/archopht.1980.01020040230003. [DOI] [PubMed] [Google Scholar]
  5. Kiehl H., Kirsch I., Lommatzsch P. Das Uberleben nach Behandlung des malignen Melanoms der Aderhaut: Vergleich von konservativer Therapie (106Ru/106Rh Applikator) und Enukleation ohne und mit postoperativer Orbitabestrahlung, 1960 bis 1979. Klin Monbl Augenheilkd. 1984 Jan;184(1):2–14. doi: 10.1055/s-2008-1054399. [DOI] [PubMed] [Google Scholar]
  6. LEDERMAN M. Radiotherapy of malignant melanomata of the eye. Br J Radiol. 1961 Jan;34:21–42. doi: 10.1259/0007-1285-34-397-21. [DOI] [PubMed] [Google Scholar]
  7. Lommatzsch P. K. Beta irradiation of conjunctival melanomas. Trans Ophthalmol Soc U K. 1977 Sep;97(3):378–380. [PubMed] [Google Scholar]
  8. Lommatzsch P. K. beta-Irradiation of choroidal melanoma with 106Ru/106Rh applicators. 16 Years' experience. Arch Ophthalmol. 1983 May;101(5):713–717. doi: 10.1001/archopht.1983.01040010713002. [DOI] [PubMed] [Google Scholar]
  9. Lommatzsch P. K. beta-Ray treatment of malignant epibulbar melanoma. Albrecht Von Graefes Arch Klin Exp Ophthalmol. 1978 Dec 15;209(2):111–124. doi: 10.1007/BF00407844. [DOI] [PubMed] [Google Scholar]
  10. NOTTER G. Das maligne epibulbäre Melanom; Bericht über 35 Patienten. Strahlentherapie. 1955 Apr;96(4):517–537. [PubMed] [Google Scholar]
  11. Stefani F. H. A prognostic index for patients with malignant melanoma of the conjunctiva. Graefes Arch Clin Exp Ophthalmol. 1986;224(6):580–582. doi: 10.1007/BF02154748. [DOI] [PubMed] [Google Scholar]

Articles from The British Journal of Ophthalmology are provided here courtesy of BMJ Publishing Group

RESOURCES